Literature DB >> 25907361

Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.

Zhaoming Wang1,2, Preetha Rajaraman1, Beatrice S Melin3, Charles C Chung1,2, Weijia Zhang4, Roberta McKean-Cowdin5, Dominique Michaud6,7, Meredith Yeager1,2, Anders Ahlbom8, Demetrius Albanes1, Ulrika Andersson3, Laura E Beane Freeman1, Julie E Buring9, Mary Ann Butler10, Tania Carreón10, Maria Feychting8, Susan M Gapstur11, J Michael Gaziano9,12, Graham G Giles13,14, Goran Hallmans15, Roger Henriksson3, Judith Hoffman-Bolton16, Peter D Inskip1, Cari M Kitahara1, Loic Le Marchand17, Martha S Linet1, Shengchao Li1,2, Ulrike Peters18,19, Mark P Purdue1, Nathaniel Rothman1, Avima M Ruder10, Howard D Sesso9, Gianluca Severi13,14, Meir Stampfer20,21, Victoria L Stevens11, Kala Visvanathan16,22, Sophia S Wang23, Emily White18,19, Anne Zeleniuch-Jacquotte24, Robert Hoover1, Joseph F Fraumeni1, Nilanjan Chatterjee1, Patricia Hartge1, Stephen J Chanock1.   

Abstract

We confirmed strong association of rs78378222:A>C (per allele odds ratio [OR] = 3.14; P = 6.48 × 10(-11) ), a germline rare single-nucleotide polymorphism (SNP) in TP53, via imputation of a genome-wide association study of glioma (1,856 cases and 4,955 controls). We subsequently performed integrative analyses on the Cancer Genome Atlas (TCGA) data for GBM (glioblastoma multiforme) and LUAD (lung adenocarcinoma). Based on SNP data, we imputed genotypes for rs78378222 and selected individuals carrying rare risk allele (C). Using RNA sequencing data, we observed aberrant transcripts with ∼3 kb longer than normal for those individuals. Using exome sequencing data, we further showed that loss of haplotype carrying common protective allele (A) occurred somatically in GBM but not in LUAD. Our bioinformatic analysis suggests rare risk allele (C) disrupts mRNA termination, and an allelic loss of a genomic region harboring common protective allele (A) occurs during tumor initiation or progression for glioma.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  TCGA; TP53; glioma; rare SNP

Mesh:

Substances:

Year:  2015        PMID: 25907361      PMCID: PMC4750473          DOI: 10.1002/humu.22799

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Rare variants in TP53 and susceptibility to neuroblastoma.

Authors:  Sharon J Diskin; Mario Capasso; Maura Diamond; Derek A Oldridge; Karina Conkrite; Kristopher R Bosse; Mike R Russell; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris
Journal:  J Natl Cancer Inst       Date:  2014-03-14       Impact factor: 13.506

2.  A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

Authors:  Simon N Stacey; Patrick Sulem; Aslaug Jonasdottir; Gisli Masson; Julius Gudmundsson; Daniel F Gudbjartsson; Olafur T Magnusson; Sigurjon A Gudjonsson; Bardur Sigurgeirsson; Kristin Thorisdottir; Rafn Ragnarsson; Kristrun R Benediktsdottir; Bjørn A Nexø; Anne Tjønneland; Kim Overvad; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Kari Hemminki; Cristina Corredera; Victoria Fuentelsaz; Pilar Grasa; Sebastian Navarrete; Fernando Fuertes; Maria D García-Prats; Enrique Sanambrosio; Angeles Panadero; Ana De Juan; Almudena Garcia; Fernando Rivera; Dolores Planelles; Virtudes Soriano; Celia Requena; Katja K Aben; Michelle M van Rossum; Ruben G H M Cremers; Inge M van Oort; Dick-Johan van Spronsen; Jack A Schalken; Wilbert H M Peters; Brian T Helfand; Jenny L Donovan; Freddie C Hamdy; Daniel Badescu; Ovidiu Codreanu; Mariana Jinga; Irma E Csiki; Vali Constantinescu; Paula Badea; Ioan N Mates; Daniela E Dinu; Adrian Constantin; Dana Mates; Sjofn Kristjansdottir; Bjarni A Agnarsson; Eirikur Jonsson; Rosa B Barkardottir; Gudmundur V Einarsson; Fridbjorn Sigurdsson; Pall H Moller; Tryggvi Stefansson; Trausti Valdimarsson; Oskar T Johannsson; Helgi Sigurdsson; Thorvaldur Jonsson; Jon G Jonasson; Laufey Tryggvadottir; Terri Rice; Helen M Hansen; Yuanyuan Xiao; Daniel H Lachance; Brian Patrick O Neill; Matthew L Kosel; Paul A Decker; Gudmar Thorleifsson; Hrefna Johannsdottir; Hafdis T Helgadottir; Asgeir Sigurdsson; Valgerdur Steinthorsdottir; Annika Lindblom; Robert S Sandler; Temitope O Keku; Karina Banasik; Torben Jørgensen; Daniel R Witte; Torben Hansen; Oluf Pedersen; Viorel Jinga; David E Neal; William J Catalona; Margaret Wrensch; John Wiencke; Robert B Jenkins; Eduardo Nagore; Ulla Vogel; Lambertus A Kiemeney; Rajiv Kumar; José I Mayordomo; Jon H Olafsson; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2011-09-25       Impact factor: 38.330

3.  Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.

Authors:  Kari Hemminki; Steinar Tretli; Jan Sundquist; Tom B Johannesen; Charlotta Granström
Journal:  Lancet Oncol       Date:  2009-04-06       Impact factor: 41.316

4.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

Review 5.  Genetic insights into familial tumors of the nervous system.

Authors:  German Melean; Roberta Sestini; Franco Ammannati; Laura Papi
Journal:  Am J Med Genet C Semin Med Genet       Date:  2004-08-15       Impact factor: 3.908

6.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

7.  Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Authors:  Yong Li; Michael W Gordon; Zijun Y Xu-Monette; Carlo Visco; Alexander Tzankov; Dehui Zou; Lugui Qiu; Santiago Montes-Moreno; Karen Dybkaer; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Qin Huang; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Jane N Winter; Ronald S Go; Miguel A Piris; Michael B Møller; Lin Wu; Michael Wang; Kenneth S Ramos; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

8.  Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites.

Authors:  Xiaoxiang Guan; Li-E Wang; Zhensheng Liu; Erich M Sturgis; Qingyi Wei
Journal:  J Cell Mol Med       Date:  2013-06-07       Impact factor: 5.310

9.  Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Authors:  Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

10.  Germline mutations in shelterin complex genes are associated with familial glioma.

Authors:  Matthew N Bainbridge; Georgina N Armstrong; M Monica Gramatges; Alison A Bertuch; Shalini N Jhangiani; Harsha Doddapaneni; Lora Lewis; Joseph Tombrello; Spyros Tsavachidis; Yanhong Liu; Ali Jalali; Sharon E Plon; Ching C Lau; Donald W Parsons; Elizabeth B Claus; Jill Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Kyle M Walsh; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Patricia A Thompson; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy
Journal:  J Natl Cancer Inst       Date:  2014-12-07       Impact factor: 11.816

View more
  10 in total

1.  The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma.

Authors:  Elena N Voropaeva; Yuriy L Orlov; Tatiana I Pospelova; Anna A Gurageva; Mikhail I Voevoda; Vladimir N Maksimov; Olga B Seregina; Maria I Churkina
Journal:  PeerJ       Date:  2020-11-12       Impact factor: 2.984

2.  CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms.

Authors:  George S Krasnov; Alexey A Dmitriev; Nataliya V Melnikova; Andrew R Zaretsky; Tatiana V Nasedkina; Alexander S Zasedatelev; Vera N Senchenko; Anna V Kudryavtseva
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

Review 3.  Genome-Wide Association Studies in Glioma.

Authors:  Ben Kinnersley; Richard S Houlston; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-30       Impact factor: 4.254

4.  Development of risk prediction models for glioma based on genome-wide association study findings and comprehensive evaluation of predictive performances.

Authors:  Yingjie Zhao; Gong Chen; Hongjie Yu; Lingna Hu; Yunmeng Bian; Dapeng Yun; Juxiang Chen; Ying Mao; Hongyan Chen; Daru Lu
Journal:  Oncotarget       Date:  2016-07-28

5.  Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.

Authors:  Qipan Deng; Hui Hu; Xinfang Yu; Shuanglin Liu; Lei Wang; Weiqun Chen; Chi Zhang; Zhaoyang Zeng; Ya Cao; Zijun Y Xu-Monette; Ling Li; Mingzhi Zhang; Steven Rosenfeld; Shideng Bao; Eric Hsi; Ken H Young; Zhongxin Lu; Yong Li
Journal:  Nat Commun       Date:  2019-11-07       Impact factor: 14.919

Review 6.  The Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes.

Authors:  Wendy Yi-Ying Wu; Gunnar Johansson; Carl Wibom; Thomas Brännström; Annika Malmström; Roger Henriksson; Irina Golovleva; Melissa L Bondy; Ulrika Andersson; Anna M Dahlin; Beatrice Melin
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

7.  Blood functional assay for rapid clinical interpretation of germline TP53 variants.

Authors:  Sabine Raad; Marion Rolain; Sophie Coutant; Céline Derambure; Raphael Lanos; Françoise Charbonnier; Jacqueline Bou; Emilie Bouvignies; Gwendoline Lienard; Stéphanie Vasseur; Michael Farrell; Olivier Ingster; Stéphanie Baert Desurmont; Edwige Kasper; Gaëlle Bougeard; Thierry Frébourg; Isabelle Tournier
Journal:  J Med Genet       Date:  2020-10-13       Impact factor: 6.318

8.  Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases.

Authors:  Jiangfen Zhou; Mingyao Lai; Yang Ni; Shaoqun Li; Junjie Zhen; Furong Du; Xing Zhang; Chao Song; Linbo Cai
Journal:  Pathol Oncol Res       Date:  2022-08-04       Impact factor: 2.874

Review 9.  The importance of p53 pathway genetics in inherited and somatic cancer genomes.

Authors:  Giovanni Stracquadanio; Xuting Wang; Marsha D Wallace; Anna M Grawenda; Ping Zhang; Juliet Hewitt; Jorge Zeron-Medina; Francesc Castro-Giner; Ian P Tomlinson; Colin R Goding; Kamil J Cygan; William G Fairbrother; Laurent F Thomas; Pål Sætrom; Federica Gemignani; Stefano Landi; Benjamin Schuster-Böckler; Douglas A Bell; Gareth L Bond
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

10.  Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.

Authors:  José Alberto Carlos-Escalante; Liliana Gómez-Flores-Ramos; Xiaopeng Bian; Alexander Perdomo-Pantoja; Kelvin César de Andrade; Sonia Iliana Mejía-Pérez; Bernardo Cacho-Díaz; Rodrigo González-Barrios; Nancy Reynoso-Noverón; Ernesto Soto-Reyes; Thalía Estefanía Sánchez-Correa; Lissania Guerra-Calderas; Chunhua Yan; Qingrong Chen; Clementina Castro-Hernández; Silvia Vidal-Millán; Lucía Taja-Chayeb; Olga Gutiérrez; Rosa María Álvarez-Gómez; Juan Luis Gómez-Amador; Patricia Ostrosky-Wegman; Alejandro Mohar-Betancourt; Luis Alonso Herrera-Montalvo; Teresa Corona; Daoud Meerzaman; Talia Wegman-Ostrosky
Journal:  Cell Mol Neurobiol       Date:  2020-06-13       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.